Inbunden, Engelska, 2017
Del 16 i serien Resistance to Targeted Anti-Cancer Therapeutics
Resistance to Targeted Therapies in Breast Cancer
2199 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Finns i fler format
Beskrivning
Produktinformation
- Utgivningsdatum: 2017-12-13
- Mått: 155 x 235 x 17 mm
- Vikt: 419 g
- Format: Inbunden
- Språk: Engelska
- Serie: Resistance to Targeted Anti-Cancer Therapeutics
- Antal sidor: 184
- Förlag: Springer International Publishing AG
- ISBN: 9783319701417
Utforska kategorier
Mer information
Dr. Prosperi received her BA in Microbiology from Miami University (OH), and went on to get a PhD in Integrated Biomedical Science (focus: Cancer Biology) at The Ohio State University. She joined a laboratory focused on breast cancer research, and started volunteering at The James Cancer Hospital and with The Komen Foundation. She then completed postdoctoral studies at the University of Chicago, where she started to focus on the APC tumor suppressor and developing targeted therapies for breast cancer. In 2012, she was recruited to Indiana University School of Medicine – South Bend with an adjunct faculty position at the University of Notre Dame. Through these affiliations, she has been a member of both the Simon Cancer Center and the Harper Cancer Research Institute since 2012. Her laboratory is focused on the understanding of resistance to chemotherapy in breast cancer patients, specifically how the APC tumor suppressor impacts this process.
Butikslager
Ej i lager i butik.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.